| Expression pattern: |
UP |
| Associated gene: |
IGF2BP2, Slug mRNA |
| Associated microRNA: |
- |
| Biological function: |
Promotes proliferation, invasion, EMT, metastasis-related malignant progression, xenograft tumor growth, and MMP9 expression in NSCLC. |
| Molecular mechanism: |
Hsa_circ_0081111 interacts with the RNA-binding protein IGF2BP2 and stabilizes Slug mRNA, increasing Slug expression and driving NSCLC proliferation, invasion, and EMT. |
| Biological pathway or process: |
proliferation (promotes); invasion (promotes); EMT (promotes); metastasis (promotes); mRNA stability (promotes); other pathway/process (promotes) |
| Detected method: |
Q
S
|
| Validation methods: |
RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; RNA-seq; Clinical Sample Validation; RNA Pull-Down; RIP (RNA Immunoprecipitation); Transfection; CCK8; Transwell Assay; In Vivo Animal Model; IHC (Immunohistochemistry); IF (Immunofluorescence); Nuclear-Cytoplasmic Fractionation; Western Blot; Bioinformatics Analysis |
| Clinical significance: |
High expression is positively correlated with TNM stage and lymph node metastasis; hsa_circ_0081111 has potential as a diagnostic and therapeutic target for NSCLC. |
| Description: |
Hsa_circ_0081111 is up-regulated in NSCLC tissues and cell lines and is associated with advanced TNM stage and lymph node metastasis. Functionally, it promotes NSCLC cell proliferation, invasion, EMT, and xenograft tumor growth. Mechanistically, cytoplasmic hsa_circ_0081111 binds the RBP IGF2BP2 to enhance Slug mRNA stability and increase Slug expression, suggesting diagnostic and therapeutic potential in NSCLC. |
| Confidence score: |
0.8508 |